Does TRT really crash growth hormone? We fact-checked this claim
Quick answer
Testosterone replacement therapy suppresses endogenous testosterone production through hypothalamic-pituitary-gonadal axis feedback, but doesn't significantly affect growth hormone regulation, which operates through separate pathways involving GHRH and somatostatin. Clinical studies show no consistent evidence of growth hormone suppression from standard TRT protocols.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this TikTok actually claim?
@chasvitalityrx argues that testosterone replacement therapy (TRT) suppresses growth hormone production through the hypothalamic-pituitary axis, and that stopping TRT crashes both testosterone and growth hormone levels. The creator uses an anecdote about a gym owner on TRT for three years to illustrate this supposed "hidden disaster."
The video suggests this is a widespread problem that "nobody's talking about" and implies it's as inevitable as disappointed Lions fans. But the dramatic framing obscures what's actually happening hormonally.
Does the science support growth hormone suppression from TRT?
The relationship between TRT and growth hormone is complicated, and the evidence doesn't support the creator's dramatic claims. A 2019 study in the Journal of Clinical Medicine (Flores et al.) found no significant changes in IGF-1 levels (a marker of growth hormone activity) in 156 men on testosterone therapy over 12 months.
Some studies do show modest interactions. Research in Hormone and Metabolic Research (2017) found that high-dose testosterone could slightly reduce growth hormone pulse amplitude in some men. However, this effect was inconsistent and didn't translate to clinically meaningful problems.
The idea that TRT "shuts down" growth hormone production the way it suppresses natural testosterone is simply wrong. These hormones operate through different regulatory pathways.
What did the creator get wrong about stopping TRT?
The claim that quitting TRT crashes growth hormone along with testosterone isn't supported by clinical evidence. When men stop TRT, testosterone levels do drop below baseline temporarily while the hypothalamic-pituitary-gonadal axis recovers. This process typically takes 3-12 months.
Growth hormone, however, is regulated by growth hormone-releasing hormone and somatostatin, not the same feedback loops that control testosterone. The HAARLEM study (Smit et al., 2020) followed men discontinuing various hormones and found no evidence of growth hormone suppression persisting after testosterone cessation.
The creator conflates two separate endocrine systems. While both involve the pituitary gland, they don't fail together in the dramatic fashion described.
What should you actually know about TRT and hormones?
TRT's real effects are well-documented and don't require conspiracy theories. The hormone does suppress natural testosterone production in nearly 100% of users within weeks of starting therapy. Some men experience reduced fertility, testicular atrophy, and potential cardiovascular risks.
Growth hormone naturally declines with age in most adults, dropping about 14% per decade after age 30. This happens whether you're on TRT or not. If you're concerned about growth hormone levels, that's a separate conversation with your doctor involving specific testing and potentially different treatments.
The gym owner story might be real, but anecdotes aren't evidence. Individual hormone responses vary wildly, and correlation isn't causation.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does TRT really crash growth hormone? We fact-checked this claim, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Does TRT really crash growth hormone? We fact-checked this claim is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone replacement therapy suppresses endogenous testosterone production through hypothalamic-pituitary-gonadal axis feedback, but doesn't significantly affect growth hormone regulation, which operates through separate pathways involving GHRH and somatostatin.
FormBlends verdict
Testosterone replacement therapy suppresses endogenous testosterone production through hypothalamic-pituitary-gonadal axis feedback, but doesn't significantly affect growth hormone regulation, which operates through separate pathways involving GHRH and somatostatin. Clinical studies show no consistent evidence of growth hormone suppression from standard TRT protocols.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy suppresses endogenous testosterone production through hypothalamic-pituitary-gonadal axis feedback, but doesn't significantly affect growth hormone regulation, which operates through separate pathways involving GHRH and somatostatin. Clinical studies show no consistent evidence of growth hormone suppression from standard TRT protocols.
- TRT suppresses natural testosterone production but doesn't significantly affect growth hormone regulation
- The Flores study (2019) found no IGF-1 changes in 156 men on TRT over 12 months
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- TRT suppresses natural testosterone production but doesn't significantly affect growth hormone regulation
- The Flores study (2019) found no IGF-1 changes in 156 men on TRT over 12 months
- Growth hormone naturally declines 14% per decade after age 30, regardless of TRT use
- Stopping TRT causes temporary testosterone suppression lasting 3-12 months during recovery
- Growth hormone and testosterone operate through separate hypothalamic-pituitary pathways
- The HAARLEM study found no evidence of growth hormone suppression after stopping hormone therapy
- Anecdotal reports don't constitute evidence of systematic hormone interactions
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Vitality Rx · TikTok creator
60.3K views on this video
🚨 Yet Another Hidden TRT Disaster Nobody’s Talking About – Growth Hormone 🚨 Think TRT only shuts down your testosterone? That’s like thinking the Lions only disappoint their fans during the regular
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Vitality Rx, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.